IMMUCELL CORPORATION - COMMON STOCK
5.1490
19-February-25 16:45:00
15 minutes delayed
Stocks
+0.1290
+2.57%
Today's range
4.8400 - 5.1700
ISIN
N/A
Source
NASDAQ
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2023
11 May 2023 16:05:01 By Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2023
04 May 2023 06:30:23 By Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2023
05 Apr 2023 16:05:35 By Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2022
21 Feb 2023 16:05:00 By Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Year Ended December 31, 2022
15 Feb 2023 11:55:13 By Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2022
09 Jan 2023 16:05:06 By Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2022
21 Nov 2022 16:05:01 By Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2022
10 Nov 2022 16:05:02 By Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Third Quarter of 2022
05 Oct 2022 06:30:00 By Nasdaq GlobeNewswire
-
ImmuCell to Participate in the Lytham Partners Fall 2022 Investor Conference
14 Sep 2022 17:01:34 By Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2022
11 Aug 2022 16:05:01 By Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2022
04 Aug 2022 06:30:00 By Nasdaq GlobeNewswire
-
ImmuCell Receives Technical Section Incomplete Letter from FDA Pertaining to Re-Tain®
27 Jul 2022 20:05:00 By Nasdaq GlobeNewswire
-
ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022
07 Jul 2022 06:30:00 By Nasdaq GlobeNewswire
-
ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders
19 May 2022 08:00:00 By Nasdaq GlobeNewswire
-
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2022
12 May 2022 16:05:02 By Nasdaq GlobeNewswire
-
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2022
10 May 2022 10:00:00 By Nasdaq GlobeNewswire
-
UPDATE -- Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement
05 May 2022 13:17:59 By Nasdaq GlobeNewswire
-
Dr. Mark Wustenberg joins ImmuCell as Commercial Leader of Stakeholder Engagement
05 May 2022 11:17:08 By Nasdaq GlobeNewswire
-
ImmuCell Announces Record Preliminary, Unaudited Sales Results for First Quarter of 2022
11 Apr 2022 16:05:00 By Nasdaq GlobeNewswire